Skip to main content
SpringerLink
Log in

Manage pain in paediatric oncology patients at the end of life using a multimodal interdisciplinary approach

  • Disease Management
  • Published:
Drugs & Therapy Perspectives Aims and scope Submit manuscript

Abstract

Pain is a common symptom experienced by paediatric oncology patients at the end of life. Correct assessment, categorization and treatment of pain are necessary to avoid unnecessary suffering. Opioids are the mainstay of treatment, with non-opioid analgesics and non-pharmacological interventions also widely used. A multimodal, interdisciplinary approach is needed to provide adequate pain control. Rarely, palliative sedation therapy may be required for patients with intolerable suffering refractory to traditional therapy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Wolfe J, Orellana L, Ullrich C, et al. Symptoms and distress in children with advanced cancer: prospective patient-reported outcomes from the PediQUEST study. J Clin Oncol. 2015;33(17):1928–35.

    Article  PubMed  PubMed Central  Google Scholar 

  2. Zernikow B, Michel E, Craig F, et al. Pediatric palliative care: use of opioids for the management of pain. Paediatr Drugs. 2009;11(2):129–51.

    Article  PubMed  Google Scholar 

  3. Snaman JM, Baker JN, Ehrentraut JH, et al. Pediatric oncology: managing pain at the end of life. Paediatr Drugs. 2016;18(3):161–80.

    Article  PubMed  Google Scholar 

  4. Contro NA, Larson J, Scofield S, et al. Hospital staff and family perspectives regarding quality of pediatric palliative care. Pediatrics. 2004;114(5):1248–52.

    Article  PubMed  Google Scholar 

  5. Palermo TM, Chambers CT. Parent and family factors in pediatric chronic pain and disability: an integrative approach. Pain. 2005;119(1–3):1–4.

    Article  PubMed  Google Scholar 

  6. Chiaretti A, Pierri F, Valentini P, et al. Current practice and recent advances in pediatric pain management. Eur Rev Med Pharmacol Sci. 2013;17(Suppl 1):112–26.

    PubMed  Google Scholar 

  7. Smith MT. Neuroexcitatory effects of morphine and hydromorphone: evidence implicating the 3-glucuronide metabolites. Clin Exp Pharmacol Physiol. 2000;27(7):524–8.

    Article  CAS  PubMed  Google Scholar 

  8. Anghelescu DL, Faughnan LG, Hankins GM, et al. Methadone use in children and young adults at a cancer center: a retrospective study. J Opioid Manag. 2011;7(5):353–61.

    PubMed  PubMed Central  Google Scholar 

  9. Guay DR. Pregabalin in neuropathic pain: a more “pharmaceutically elegant” gabapentin? Am J Geriatr Pharmacother. 2005;3(4):274–87.

    Article  CAS  PubMed  Google Scholar 

  10. Finkel JC, Pestieau SR, Quezado ZM. Ketamine as an adjuvant for treatment of cancer pain in children and adolescents. J Pain. 2007;8(6):515–21.

    Article  CAS  PubMed  Google Scholar 

  11. Klepstad P, Borchgrevink P, Hval B, et al. Longterm treatment with ketamine in a 12-year-old girl with severe neuropathic pain caused by a cervical spinal tumor. J Pediatr Hematol Oncol. 2001;23(9):616–9.

    Article  CAS  PubMed  Google Scholar 

  12. Tsui BC, Davies D, Desai S, et al. Intravenous ketamine infusion as an adjuvant to morphine in a 2-year-old with severe cancer pain from metastatic neuroblastoma. J Pediatr Hematol Oncol. 2004;26(10):678–80.

    Article  Google Scholar 

  13. Vondracek P, Oslejskova H, Kepak T, et al. Efficacy of pregabalin in neuropathic pain in paediatric oncological patients. Eur J Paediatr Neurol. 2009;13(4):332–6.

    Article  PubMed  Google Scholar 

  14. August KJ, Dalton A, Katzenstein HM, et al. The use of zoledronic acid in pediatric cancer patients. Pediatr Blood Cancer. 2011;56(4):610–4.

    Article  PubMed  Google Scholar 

  15. Smith HS, Peppin JF. Toward a systematic approach to opioid rotation. J Pain Res. 2014;7:589–608.

    CAS  PubMed  PubMed Central  Google Scholar 

  16. Palmer PP, Miller RD. Current and developing methods of patient-controlled analgesia. Anesthesiol Clin. 2010;28(4):587–99.

    Article  PubMed  Google Scholar 

  17. Berde CB, Lehn BM, Yee JD, et al. Patient-controlled analgesia in children and adolescents: a randomized, prospective comparison with intramuscular administration of morphine for postoperative analgesia. J Pediatr. 1991;118(3):460–6.

    Article  CAS  PubMed  Google Scholar 

  18. Anghelescu DL, Burgoyne LL, Oakes LL, et al. The safety of patient-controlled analgesia by proxy in pediatric oncology patients. Anesth Analg. 2005;101(6):1623–7.

    Article  PubMed  Google Scholar 

  19. Anghelescu DL, Faughnan LG, Baker JN, et al. Use of epidural and peripheral nerve blocks at the end of life in children and young adults with cancer: the collaboration between a pain service and a palliative care service. Paediatr Anaesth. 2010;20(12):1070–7.

    Article  PubMed  PubMed Central  Google Scholar 

  20. Turk DC, Swanson KS, Tunks ER. Psychological approaches in the treatment of chronic pain patients: when pills, scalpels, and needles are not enough. Can J Psychiatry. 2008;53(4):213–23.

    PubMed  Google Scholar 

  21. Anghelescu DL, Hamilton H, Faughnan LG, et al. Pediatric palliative sedation therapy with propofol: recommendations based on experience in children with terminal cancer. J Palliat Med. 2012;15(10):1082–90.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Compliance with ethical standards

The article was adapted from Pediatric Drugs 2016;18(3):161–80 [3] by salaried employees of Adis/Springer and was not supported by any external funding.

Author information

Authors and Affiliations

    Consortia

    Adis Medical Writers

    Rights and permissions

    Reprints and permissions

    About this article

    Check for updates. Verify currency and authenticity via CrossMark

    Cite this article

    Adis Medical Writers. Manage pain in paediatric oncology patients at the end of life using a multimodal interdisciplinary approach. Drugs Ther Perspect 32, 515–520 (2016). https://doi.org/10.1007/s40267-016-0344-z

    Download citation

    • Published:

    • Issue Date:

    • DOI: https://doi.org/10.1007/s40267-016-0344-z

    Keywords

    Search

    Navigation